Jason Smith

Dr. Smith led the first institutional investment in Optimeos in 2016. He joined IP Group in 2014 with extensive experience developing and commercializing healthcare technology in both start-ups and large global companies. Dr. Smith leads the US Life Science Sector for IP Group.